Microbix Biosystems Inc
TSX:MBX
Microbix Biosystems Inc
Net Income (Common)
Microbix Biosystems Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Microbix Biosystems Inc
TSX:MBX
|
Net Income (Common)
CA$3.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
Zymeworks Inc
NYSE:ZYME
|
Net Income (Common)
-$118.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Net Income (Common)
-$93.8m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Net Income (Common)
-$94.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Net Income (Common)
-$62.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-25%
|
|
Spectral Medical Inc
TSX:EDT
|
Net Income (Common)
-CA$18m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-4%
|
See Also
What is Microbix Biosystems Inc's Net Income (Common)?
Net Income (Common)
3.7m
CAD
Based on the financial report for Dec 31, 2023, Microbix Biosystems Inc's Net Income (Common) amounts to 3.7m CAD.
What is Microbix Biosystems Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
14%